September 14, 2023 — Myocardial infarction, the number one cause of sudden death in adults and the number two cause of death in Korea, is a deadly disease with an initial mortality rate of 30%, and about 5-10% of patients die even if they are transported to a medical center for treatment.

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart & Vascular Institute, has now shown through a clinical study to significantly decrease cardiovascular mortality, reduce additional non-invasive heart testing, and increase cath lab efficiency.

September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an uneven predictor of heart health with white adults benefitting the most in comparison to Black, Hispanic and Asian Americans, according to a study led by researchers at 

September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation, or ECMO--an often lifesaving treatment where blood is pumped outside of a patient’s body to a portable heart-lung machine, giving the patient’s own organs a re

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates of systolic, or top number, blood pressure being controlled during an outpatient visit appeared to slightly decrease during winter months, according to a new study presented during the American Heart Association (AHA) Hypertens

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin signaling inhibitor biologic, for adults with pulmonary arterial hypertension (PAH) (WHO Group 1) at the 

The global interventional cardiology device market is driven by the number of procedures performed across the globe

The global interventional cardiology device market is driven by the number of procedures performed across the globe.

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality. But 10-year conditional survival was similar for biventricular and most single-ventricle CHD patients, and notably better for biventricular CHD patients compared to non-CHD heart transplant recipients. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now